Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0288 Transporter Info
Gene Name	SLC35A2
Transporter Name	UDP-galactose translocator
Gene ID	7355
UniProt ID	P78381

Post-Translational Modification of This DT
Overview of SLC35A2 Modification Sites with Functional and Structural Information
Sequence	M A A V G A G G S T A A P G P G A V S A G A L E P G T A S A A H R R L K Y I S L A V L V V Q N A S L I L S I R Y A R T L P G D R F F A T T A V V M A E V L K G L T C L L L L F A Q K R G N V K H L V L F L H E A V L V Q Y V D T L K L A V P S L I Y T L Q N N L Q Y V A I S N L P A A T F Q V T Y Q L K I L T T A L F S V L M L N R S L S R L Q W A S L L L L F T G V A I V Q A Q Q A G G G G P R P L D Q N P G A G L A A V V A S C L S S G F A G V Y F E K I L K G S S G S V W L R N L Q L G L F G T A L G L V G L W W A E G T A V A T R G F F F G Y T P A V W G V V L N Q A F G G L L V A V V V K Y A D N I L K G F A T S L S I V L S T V A S I R L F G F H V D P L F A L G A G L V I G A V Y L Y S L P R G A A K A I A S A S A S A S G P C V H Q Q P P G Q P P P P Q L S S H R G D L I T E P F L P K L L T K V K G S
PTM type	X-Phosphorylation X: Amino Acid

Phosphorylation
Serine	13 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35A2			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 9 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35A2			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	19
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 19 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35A2			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	29
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 29 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC35A2			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 227 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC35A2			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	228
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 228 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC35A2			[1] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	302
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 302 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC35A2			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	304
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 304 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC35A2			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	308
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 308 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC35A2			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	312
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 312 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC35A2			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	350
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 350 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC35A2			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	352
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 352 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC35A2			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	354
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 354 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC35A2			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	356
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Serine 356 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35A2			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Threonine 10 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35A2			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	27
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Threonine 27 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35A2			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	256
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Threonine 256 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC35A2			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	260
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Threonine 260 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC35A2			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Threonine 301 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC35A2			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	309
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A2 Threonine 309 has the potential to affect its expression or activity.

References
1	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
2	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
3	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
4	Sequential enrichment with titania-coated magnetic mesoporous hollow silica microspheres and zirconium arsenate-modified magnetic nanoparticles for the study of phosphoproteome of HL60 cells. J Chromatogr A. 2014 Oct 24;1365:54-60.
5	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
6	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence